214 related articles for article (PubMed ID: 26646794)
21. A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
Sun Y; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2017 Mar; 115(4):462-469. PubMed ID: 28105657
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study.
Hou N; Xiao J; Wang Z; Wu Y; Hou G; Guo L; Zhang J; Ling R
Clin Breast Cancer; 2020 Dec; 20(6):e682-e694. PubMed ID: 32713825
[TBL] [Abstract][Full Text] [Related]
24. Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer.
Kang BH; Song C; Kang SB; Lee KW; Lee HS; Kim JS
Anticancer Res; 2020 Apr; 40(4):2171-2177. PubMed ID: 32234911
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.
Roy P; Serra S; Kennedy E; Chetty R
J Surg Oncol; 2012 Feb; 105(2):130-4. PubMed ID: 21842520
[TBL] [Abstract][Full Text] [Related]
26. Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial.
Zhou J; Li T; Xiao Y; Lin J; Chen X; Peng S; Huang M; Shi X; Cai L; Huang P; Huang M
Ann Transl Med; 2022 Jun; 10(12):694. PubMed ID: 35845530
[TBL] [Abstract][Full Text] [Related]
27. Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study.
Kamiya T; Uehara K; Nakayama G; Ishigure K; Kobayashi S; Hiramatsu K; Nakayama H; Yamashita K; Sakamoto E; Tojima Y; Kawai S; Kodera Y; Nagino M;
Eur J Surg Oncol; 2016 Jun; 42(6):829-35. PubMed ID: 26968228
[TBL] [Abstract][Full Text] [Related]
28. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
[TBL] [Abstract][Full Text] [Related]
29. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
[TBL] [Abstract][Full Text] [Related]
30. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
Cienfuegos JA; Rotellar F; Baixauli J; Beorlegui C; Sola JJ; Arbea L; Pastor C; Arredondo J; Hernández-Lizoáin JL
Ann Surg Oncol; 2015 Mar; 22(3):916-23. PubMed ID: 25190129
[TBL] [Abstract][Full Text] [Related]
31. Histopathology of residual rectal carcinoma following preoperative radiochemotherapy.
Micev M; Micev-Cosić M; Todorović V; Krsmanović M; Krivokapić Z; Popović M; Barisić G; Marković V; Jelić-Radosević L; Popov I
Acta Chir Iugosl; 2004; 51(2):99-108. PubMed ID: 15771300
[TBL] [Abstract][Full Text] [Related]
32. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
Fleischmann A; Thalmann GN; Perren A; Seiler R
Am J Surg Pathol; 2014 Mar; 38(3):325-32. PubMed ID: 24525502
[TBL] [Abstract][Full Text] [Related]
33. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
34. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
35. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
[TBL] [Abstract][Full Text] [Related]
36. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
[TBL] [Abstract][Full Text] [Related]
37. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
[TBL] [Abstract][Full Text] [Related]
38. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.
Nougaret S; Rouanet P; Molinari N; Pierredon MA; Bibeau F; Azria D; Lemanski C; Assenat E; Duffour J; Ychou M; Reinhold C; Gallix B
Radiology; 2012 May; 263(2):409-18. PubMed ID: 22438364
[TBL] [Abstract][Full Text] [Related]
39. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
40. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
